For decades, multiple sclerosis research has focused on myelin, the insulation around the brain's wiring. Scientists paid ...

Researchers discover that the nerve cells that make us uniquely human are also uniquely vulnerable to dying during the waves ...

Hemispherian AS, a clinical-stage oncology company developing novel small molecule therapeutics, today announced the initiation of a first-in-human Phase 1/2a clinical trial of GLIX1 in patients with ...

A hidden mechanism in MS may be damaging neurons at their genetic core, offering a potential new way to slow the disease.

A group of nerve cells essential for cognition may be especially vulnerable to DNA damage upon exposure to inflammation in MS.

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

A new discovery is bringing light to a neglected corner of multiple sclerosis (MS) research by revealing how the disease ...

What causes gray matter loss in Multiple Sclerosis? New research identifies DNA damage in CUX2 neurons as a primary driver of MS progression.

Discovery reshapes understanding of how tumor cells repair broken DNA, pointing toward more precise cancer therapies.

Oestrogen-induced DNA damage drives genomic instability in BRCA1 mutation cells, with dietary compounds showing protective potential.